Risk of Substance Use Disorders in Children Treated With Psychotropics

<p>In this episode, we discuss a meta-analysis that included 6 million patients to assess whether pharmacotherapy increases the risk of substance use or misuse, specifically the risk of using stimulant medications in children with ADHD.</p> <p>Faculty: David Rosenberg, M.D.<br /> Host: Richard Seeber, M.D.</p> <ul> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC214" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/publication/cap-smart-takes-vol-03-2742?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC214" target="_blank" rel="noopener"><strong>Earn 0.5 CMEs: Smart Takes Vol. 03</strong></a></li> <li style="font-weight: bold;"><a href= "https://psychopharmacologyinstitute.com/section/impact-of-pharmacotherapy-of-childhood-onset-psychiatric-disorders-on-the-development-of-substance-use-disorders-2742-5296?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC214" target="_blank" rel="noopener"><strong>Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders</strong></a></li> </ul>